We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
EOLS

Price
6.72
Stock movement down
-0.14 (-2.04%)
Company name
Evolus Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
434.69M
Ent value
573.37M
Price/Sales
1.75
Price/Book
73.80
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
47.32
PEG
-
EPS growth
-10.81%
1 year return
-58.70%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-10-30

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

EOLS does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.75
Price to Book73.80
EV to Sales2.31

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count64.69M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)0.21

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash43.52M
Net receivables50.44M
Total current assets134.89M
Goodwill21.21M
Intangible assets48.72M
Property, plant and equipment0.00
Total assets219.00M
Accounts payable22.96M
Short/Current long term debt180.77M
Total current liabilities66.71M
Total liabilities247.76M
Shareholder's equity0.00
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open6.78
Daily high7.14
Daily low6.67
Daily Volume953K
All-time high38.49
1y analyst estimate19.00
Beta0.88
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date11 Nov 2025

Downside potential

Loading...
Downside potential data
EOLSS&P500
Current price drop from All-time high-82.54%-1.10%
Highest price drop-85.01%-19.00%
Date of highest drop11 Aug 20258 Apr 2025
Avg drop from high-72.06%-2.76%
Avg time to new high-5 days
Max time to new high266 days89 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
EOLS (Evolus Inc) company logo
Marketcap
434.69M
Marketcap category
Small-cap
Description
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Employees
329
Investor relations
-
SEC filings
CEO
David Moatazedi
Country
USA
City
Newport Beach
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...